HHLR Advisors’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SGMT
HHLR Advisors's SGMT Position: Q3 2026 in Review
HHLR Advisors sold out of Sagimet Biosciences (SGMT) in Q3 2026, closing a stake of 724,800 shares — an estimated $5.6M sold.
HHLR Advisors first reported a position in SGMT in Q3 2023 and held it in 12 quarters. The position peaked at $12.8M in Q3 2023. 153 funds tracked by Wall St. Rank hold SGMT as of Q3 2026.
- HHLR Advisors reported no remaining Sagimet Biosciences position as of Q3 2026 after selling out during the quarter.
- HHLR Advisors sold 724,800 Sagimet Biosciences shares in Q3 2026, an estimated $5.6M.
- HHLR Advisors first reported a position in Sagimet Biosciences in Q3 2023 and held it in 12 quarters.
- HHLR Advisors's Sagimet Biosciences position peaked at $12.8M in Q3 2023.
- 153 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q3 2026.
Based on HHLR Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.